Vanguard Group Inc Deciphera Pharmaceuticals, Inc. Transaction History

Vanguard Group Inc

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 10, 2024	BUY	$13.58 - $17.36 $2.22 Million - $2.84 Million	163,408 Added 3.71%	4,565,044 $71.8 Million
Q4 2023 Feb 14, 2024	BUY	$10.11 - $16.54 $335,682 - $549,177	33,203 Added 0.76%	4,401,636 $71 Million
Q3 2023 Nov 14, 2023	SELL	$12.46 - $15.48 $297,009 - $368,996	-23,837 Reduced 0.54%	4,368,433 $55.6 Million
Q2 2023 Aug 14, 2023	SELL	$13.28 - $15.96 $2.91 Million - $3.49 Million	-218,820 Reduced 4.75%	4,392,270 $61.8 Million
Q1 2023 May 15, 2023	SELL	$14.26 - $22.1 $1.91 Million - $2.97 Million	-134,231 Reduced 2.83%	4,611,090 $71.2 Million
Q4 2022 Feb 10, 2023	SELL	$14.85 - $19.04 $737,629 - $945,754	-49,672 Reduced 1.04%	4,745,321 $77.8 Million
Q3 2022 Nov 14, 2022	BUY	$12.38 - $20.23 $4.98 Million - $8.13 Million	402,047 Added 9.15%	4,794,993 $88.7 Million
Q2 2022 Aug 12, 2022	BUY	$9.11 - $13.98 $7.27 Million - $11.2 Million	798,434 Added 22.21%	4,392,946 $57.8 Million
Q1 2022 May 13, 2022	BUY	$6.87 - $11.11 $860,089 - $1.39 Million	125,195 Added 3.61%	3,594,512 $33.3 Million
Q4 2021 Feb 14, 2022	SELL	$7.7 - $37.13 $3.6 Million - $17.3 Million	-467,068 Reduced 11.87%	3,469,317 $33.9 Million
Q3 2021 Nov 12, 2021	BUY	$26.46 - $37.15 $229,699 - $322,499	8,681 Added 0.22%	3,936,385 $134 Million
Q2 2021 Aug 13, 2021	BUY	$32.73 - $47.95 $129 Million - $188 Million	3,927,704 New	3,927,704 $144 Million

293K

500

Ticker DCPH
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 66,822,100
Description
Deciphera Pharmaceuticals, Inc., a biopharmaceutical company, develops drugs to enhance the lives of cancer patients by addressing key mechanisms of drug resistance that limit the rate and durability of response to existing cancer therapies in the United States and internationally. Its lead drug candidate is QINLOCK used for the treatment of gas...

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

Stay updated on Vanguard Group Inc with notifications on news.